A 30-day supply of oral berberine capsules (1,000 mg/day) costs $10 to $15
SURPASS-1 shows that tirzepatide alone, at all doses, was superior to placebo and revealed a dose-dependent reduction of HbA1c by up to 2.07% (p 10% weight loss can be disease modifying and may even lead to disease remission [38]
Understanding the whole patient prior to receiving transplant and cellular therapy: Real-world data on patients financial toxicity prior to receiving treatment Miranda Kapfhammer 1 , Rachel Cusatis 1 , Deborah Mattila 2 , Sarah Smith 2 1 Medical College of Wisconsin, Milwaukee, USA, 2 National Marrow Donor Program (NMDP), Minneapolis, USA Aims Cellular therapy (CT) recipients are at high risk for financial toxicity (FT) given the frequent need for temporary re-location, loss of income for patients and caregivers in addition to the expected medical expenses of cancer care
More and more advertisements for weight loss medications are appearing in peoples daily lives
